Clinical Trials Directory

Trials / Unknown

UnknownNCT02548221

Impact of Large-Volume Pleural Effusions on Heart Function

The Assessment of Heart Function Using Transthoracic Echocardiogram (TTE) Following Thoracentesis on Large-volume Pleural Effusions

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Beijing Chao Yang Hospital · Academic / Other
Sex
All
Age
14 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The physiologic basis for relief from dyspnea after therapeutic thoracentesis remains poorly understood. Improvement of the heart and lung function may contribute to the dyspnea relief. But there is no data support this phenomenon. Transthoracic echocardiogram (TTE) is a non-invasive viewing of the heart, which can quickly assess the heart function through real-time images. The investigators performed thoracentesis on patients with large-volume pleural effusions, and utilized TTE to access the change of heart and lung function before and after this medical procedure.

Detailed description

Patients with large pleural effusions often experience dramatic and immediate relief from dyspnea after therapeutic thoracentesis. Although this is a well-recognized phenomenon, the physiologic basis for such relief remains poorly understood. Primary physiologic basis for the relief in dyspnea after thoracentesis may include the improvement of the heart and lung function. In some cases the improvement in breathlessness cannot be attributed to the improvement of gas exchange, due to the atelectatic lung(not fully expansion of the lung). Transthoracic echocardiogram (TTE) is a non-invasive, real-time viewing of the internal parts of the heart using ultrasound, which can get highly accurate and quick assessment of the various heart images, though which doctors can quickly assess a patient's heart valves and degree of heart muscle contraction.

Conditions

Interventions

TypeNameDescription
DEVICEtransthoracic echocardiogramThoracentesis was performed on patients with large-volume pleural effusions, and TTE was utilized to access the change of heart and lung function before and after this medical procedure.

Timeline

Start date
2015-09-01
Primary completion
2015-12-01
Completion
2016-12-01
First posted
2015-09-14
Last updated
2015-09-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02548221. Inclusion in this directory is not an endorsement.